Funding Details
- Awarder
- YCombinator
- Date Award
- March 10, 2023
- Vertical
- Healthcare,Drug Discovery and Delivery
- Funding URL
- View Funding Page
- Valuation
-
$0
Company Info
- Founding Year
- 2023
- Company Description
- Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material.
Our killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.
- Market
- Healthcare
- Location
-
Munich,
BY,
Germany
- Coinvestors
- YCombinator
Links